Prophylactic anticoagulation decreases catheter-related thrombosis and occlusion in children with home parenteral nutrition

JPEN J Parenter Enteral Nutr. 2012 Jul;36(4):456-62. doi: 10.1177/0148607111416482. Epub 2012 Jan 12.

Abstract

Background: Home parenteral nutrition (PN) has improved the survival of children with intestinal failure. Important complications include catheter-related thrombosis, occlusion, and infection. This study evaluated the efficacy and safety of prophylactic anticoagulation in the prevention of these complications.

Methods: Medical records were retrospectively reviewed of all children (0-18 years) with PN between January 1994 and March 2007 in 1 tertiary center. After introduction of prophylactic low molecular weight heparin or vitamin K antagonists in March 2007, all patients were prospectively followed until March 2010.

Results: In sum, 14 patients did not receive prophylaxis; 13 switched from no prophylaxis to prophylaxis in March 2007; and 5 directly received prophylaxis. Median age of PN onset was 4 months (range, 0.1-202) in the nonprophylaxis group (n = 27) and 25 (range, 2-167) in the prophylaxis group (n = 18); 16 children received low molecular weight heparin and 2, vitamin K antagonists. Catheter-related thrombosis developed in 9 patients with no prophylaxis (33%) and 1 with prophylaxis (6%) (P = .034). Cumulative 5-year thrombosis-free survival was 48% and 93% in the nonprophylaxis and prophylaxis groups, respectively (P = .047). Per 1,000 PN days, the nonprophylaxis and prophylaxis groups had 2.6 and 0.1 occlusions (P = .04) and 4.6 and 2.1 infections (P = .06), respectively. Cumulative infection-free survival after 3 years was 19% and 46% in the nonprophylaxis and prophylaxis groups, respectively (P = .03). Bleeding complications did not occur.

Conclusion: Thromboprophylaxis significantly decreased catheter-related thrombosis and occlusion in children with PN without complications.

MeSH terms

  • Adolescent
  • Blood Coagulation / drug effects*
  • Catheterization, Central Venous / methods
  • Catheters / adverse effects*
  • Child
  • Child, Preschool
  • Drug Evaluation
  • Female
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Infant
  • Male
  • Parenteral Nutrition, Home / methods*
  • Retrospective Studies
  • Thrombosis / drug therapy
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Treatment Outcome
  • Vitamin K / antagonists & inhibitors
  • Vitamin K / therapeutic use

Substances

  • Heparin, Low-Molecular-Weight
  • Vitamin K